BREAKING NEWS: FDA advisory committee has unanimously recommended a booster dose of Moderna’s COVID-19 vaccine for those aged 65 and older and at high risk due to underlying conditions or their jobs
- The FDA’s advisory committee has voted to recommend approval of Covid booster shots of Moderna’s vaccine
- Boosters shots will only be approved for those aged 65 and older at high risk due to their jobs
An advisory committee for the U.S. Food and Drug Administration (FDA) has voted to recommend approval of booster doses of Moderna‘s COVID-19.
The boosters have only been approved for older adults aged 65 and older and those who are at high risk of developing a severe case of the virus due to underlying conditions.
It comes almost exactly one month after the Vaccines and Related Biological Products Advisory Committee (VRBPAC) approved boosters for the Pfizer-BioNTech vaccine
The FDA’s advisory committee has voted to recommend approval of Covid booster shots of Moderna’s vaccine. Pictured: A healthcare worker holds a vial of the Moderna COVID-19 vaccine in New York City, January 2021
This is a breaking news story and will be updated.
Share or comment on this article: